Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Below Guidance

Go back to Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Below Guidance
(NASDAQ: AQST) Delayed: 4.24 +0.06 (1.44%)
Previous Close $4.18    52 Week High
Open $4.19    52 Week Low
Day High $4.29    P/E N/A 
Day Low $4.18    EPS
Volume 1,468,623